Jay kumar yadav (31 resultados)

Condición: New.

Condición: New.

Condición: New.

Condición: New.

HRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.

HRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.

Condición: As New. Unread book in perfect condition.

Condición: New. In English.

Condición: New.

Condición: As New. Unread book in perfect condition.

Condición: New.

Hardcover. Condición: new. Hardcover. This book explores the potential of nanotechnology in treating metabolic disorders, highlighting its potential to improve drug delivery, early disease detection, and precision therapeutics. Metabolic syndrome is a significant global health challenge, with a five-fld increase in the risk of developing type-2 diabetes and a two-fold heightened risk of cardiovascular diseases. Despite advancements in understanding the pathogenesis of metabolic syndrome, current therapeutic interventions have not achieved optimal efficacy. The integration of nanotechnology into biomedicine is seen as a promising avenue to address this issue.Nanoparticles can be engineered to carry anti-inflammatory agents, providing targeted relief at inflammation sites, reducing inflammation and minimizing systemic side effects. Nanotechnology also enhances drug delivery systems by navigating biological barriers and reaching specific sites with precision. This not only improves the bioavailability of therapeutic agents but also minimizes off-target effects, enhancing overall treatment effectiveness.Nanotechnology also plays a pivotal role in early disease detection and diagnosis through innovative nano-imaging techniques. These techniques enable the visualization of molecular and cellular events at unprecedented resolutions, facilitating the identification of metabolic syndrome markers and associated disorders at their incipient stages. As research progresses, the integration of nanotechnology has the potential to redefine metabolic syndrome management, offering hope for improved patient outcomes and a healthier global population.The chapters cover metabolic syndromes, including insulin resistance, hypertension, dyslipidemia, type 2 diabetes, obesity, inflammation, and non-alcoholic fatty liver disease. It provides up-to-date literature on mechanistic understanding and therapeutic strategies. It is a valuable resource for UG/PG students, clinicians, academicians, scientists, researchers, and industrial specialists in advanced materials science, flexible electronics, nanoelectronics, energy, environmental, and biomedical sciences. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Condición: New.

Buch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book explores the potential of nanotechnology in treating metabolic disorders, highlighting its potential to improve drug delivery, early disease detection, and precision therapeutics. Metabolic syndrome is a significant global health challenge, with a five-fld increase in the risk of developing type-2 diabetes and a two-fold heightened risk of cardiovascular diseases. Despite advancements in understanding the pathogenesis of metabolic syndrome, current therapeutic interventions have not achieved optimal efficacy. The integration of nanotechnology into biomedicine is seen as a promising avenue to address this issue.Nanoparticles can be engineered to carry anti-inflammatory agents, providing targeted relief at inflammation sites, reducing inflammation and minimizing systemic side effects. Nanotechnology also enhances drug delivery systems by navigating biological barriers and reaching specific sites with precision. This not only improves the bioavailability of therapeutic agents but also minimizes off-target effects, enhancing overall treatment effectiveness.Nanotechnology also plays a pivotal role in early disease detection and diagnosis through innovative nano-imaging techniques. These techniques enable the visualization of molecular and cellular events at unprecedented resolutions, facilitating the identification of metabolic syndrome markers and associated disorders at their incipient stages. As research progresses, the integration of nanotechnology has the potential to redefine metabolic syndrome management, offering hope for improved patient outcomes and a healthier global population.The chapters cover metabolic syndromes, including insulin resistance, hypertension, dyslipidemia, type 2 diabetes, obesity, inflammation, and non-alcoholic fatty liver disease. It provides up-to-date literature on mechanistic understanding and therapeutic strategies. It is a valuable resource for UG/PG students, clinicians, academicians, scientists, researchers, and industrial specialists in advanced materials science, flexible electronics, nanoelectronics, energy, environmental, and biomedical sciences.…

Condición: New.

Condición: New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.…

Hardcover. Condición: Brand New. 320 pages. 9.25x6.10x9.49 inches. In Stock.

Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 212 pp. Englisch.

Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 212 pp. Englisch.

Condición: New. Print on Demand.

Condición: New. PRINT ON DEMAND.

Condición: new. Questo è un articolo print on demand.

Taschenbuch. Condición: Neu. Ecofriendly Management of Foliar Diseases in Indian Mustard | Management of Foliar Diseases in Indian Mustard Second Edition | Jay Kumar Yadav (u. a.) | Taschenbuch | Englisch | 2026 | LAP LAMBERT Academic Publishing | EAN 9786209609817 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu Print on Demand.…

Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Indian mustard [Brassica juncea (L.) Czern & Coss.] is an important oil seed crop, grown both in tropical and subtropical regions of the world. It is an important edible oil that cannot be easily replaced. Indian mustard belongs to the family Brassicaceae. It is one of the second-most important rabi oilseed crops after groundnut and accounts for nearly 30% of the total oilseed production in the country. They occupy a prominent place, being next in importance to groundnuts, both in area and production, They meet the fat requirement of about 50% of the population in the country and are grown under a wide range of agro-climatic conditions. Indian mustard is the most important member of the group, accounting for more than 70% of the area under rapeseed and mustard, followed by Toria, Yellow Sarason and Brown Sarason.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 212 pp. Englisch. …

Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Indian mustard [Brassica juncea (L.) Czern & Coss.] is an important oil seed crop, grown both in tropical and subtropical regions of the world. It is an important edible oil that cannot be easily replaced. Indian mustard belongs to the family Brassicaceae. It is one of the second-most important rabi oilseed crops after groundnut and accounts for nearly 30% of the total oilseed production in the country. They occupy a prominent place, being next in importance to groundnuts, both in area and production, They meet the fat requirement of about 50% of the population in the country and are grown under a wide range of agro-climatic conditions. Indian mustard is the most important member of the group, accounting for more than 70% of the area under rapeseed and mustard, followed by Toria, Yellow Sarason and Brown Sarason.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 212 pp. Englisch. …

Buch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book explores the potential of nanotechnology in treating metabolic disorders, highlighting its potential to improve drug delivery, early disease detection, and precision therapeutics. Metabolic syndrome is a significant global health challenge, with a five-fld increase in the risk of developing type-2 diabetes and a two-fold heightened risk of cardiovascular diseases. Despite advancements in understanding the pathogenesis of metabolic syndrome, current therapeutic interventions have not achieved optimal efficacy. The integration of nanotechnology into biomedicine is seen as a promising avenue to address this issue.Nanoparticles can be engineered to carry anti-inflammatory agents, providing targeted relief at inflammation sites, reducing inflammation and minimizing systemic side effects. Nanotechnology also enhances drug delivery systems by navigating biological barriers and reaching specific sites with precision. This not only improves the bioavailability of therapeutic agents but also minimizes off-target effects, enhancing overall treatment effectiveness.Nanotechnology also plays a pivotal role in early disease detection and diagnosis through innovative nano-imaging techniques. These techniques enable the visualization of molecular and cellular events at unprecedented resolutions, facilitating the identification of metabolic syndrome markers and associated disorders at their incipient stages. As research progresses, the integration of nanotechnology has the potential to redefine metabolic syndrome management, offering hope for improved patient outcomes and a healthier global population.The chapters cover metabolic syndromes, including insulin resistance, hypertension, dyslipidemia, type 2 diabetes, obesity, inflammation, and non-alcoholic fatty liver disease. It provides up-to-date literature on mechanistic understanding and therapeutic strategies. It is a valuable resource for UG/PG students, clinicians, academicians, scientists, researchers, and industrial specialists in advanced materials science, flexible electronics, nanoelectronics, energy, environmental, and biomedical sciences. 506 pp. Englisch.…

Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt.

Buch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book explores the potential of nanotechnology in treating metabolic disorders, highlighting its potential to improve drug delivery, early disease detection, and precision therapeutics. Metabolic syndrome is a significant global health challenge, with a five-fld increase in the risk of developing type-2 diabetes and a two-fold heightened risk of cardiovascular diseases. Despite advancements in understanding the pathogenesis of metabolic syndrome, current therapeutic interventions have not achieved optimal efficacy. The integration of nanotechnology into biomedicine is seen as a promising avenue to address this issue.Nanoparticles can be engineered to carry anti-inflammatory agents, providing targeted relief at inflammation sites, reducing inflammation and minimizing systemic side effects. Nanotechnology also enhances drug delivery systems by navigating biological barriers and reaching specific sites with precision. This not only improves the bioavailability of therapeutic agents but also minimizes off-target effects, enhancing overall treatment effectiveness.Nanotechnology also plays a pivotal role in early disease detection and diagnosis through innovative nano-imaging techniques. These techniques enable the visualization of molecular and cellular events at unprecedented resolutions, facilitating the identification of metabolic syndrome markers and associated disorders at their incipient stages. As research progresses, the integration of nanotechnology has the potential to redefine metabolic syndrome management, offering hope for improved patient outcomes and a healthier global population.The chapters cover metabolic syndromes, including insulin resistance, hypertension, dyslipidemia, type 2 diabetes, obesity, inflammation, and non-alcoholic fatty liver disease. It provides up-to-date literature on mechanistic understanding and therapeutic strategies. It is a valuable resource for UG/PG students, clinicians, academicians, scientists, researchers, and industrial specialists in advanced materials science, flexible electronics, nanoelectronics, energy, environmental, and biomedical sciences.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 528 pp. Englisch.…

Paperback. Condición: new. Paperback. Nano-Bio-Medicine for Gastrointestinal Diseases This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.

Condición: New. Print on Demand.